ATAI Life Sciences NV

( )
ATAI PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
PFEPfizer Inc. 0.51%51.740.9%$2185.75m
JNJJohnson & Johnson 0.26%163.370.7%$1368.59m
MRKMerck & Co., Inc. -1.55%72.280.7%$1045.98m
BMYBristol-Myers Squibb Co. 0.50%57.121.0%$821.40m
LLYEli Lilly & Co. -0.47%245.181.1%$704.90m
ABBVAbbVie, Inc. 0.12%121.501.9%$637.74m
AZNAstraZeneca Plc -1.17%54.761.0%$308.93m
NVSNovartis AG 0.19%80.680.2%$173.62m
GSKGlaxoSmithKline Plc 1.51%42.390.2%$161.58m
DRNADicerna Pharmaceuticals, Inc. -0.05%38.160.3%$155.25m
VTRSViatris, Inc. -0.32%12.400.0%$148.00m
RPRXRoyalty Pharma Plc 1.74%38.550.1%$119.40m
BFRIBiofrontera, Inc. 2.82%4.370.0%$116.32m
RGENRepligen Corp. 4.48%258.676.7%$97.18m
NVONovo Nordisk A/S 2.24%110.160.1%$84.66m

Company Profile

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company engages in the treatment of mental health disorders. The company was founded by Christian Angermayer, Florian Brand, Srinivas Rao and Lars Christian Wilde in June 2018 and is headquartered in Berlin, Germany.